Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism RIPK1 modulators(Receptor-interacting serine/threonine-protein kinase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | US | 25 May 2023 | |
Central Nervous System Diseases | Preclinical | CN | 25 May 2023 |